泰恩康：关于全资子公司收到药品注册受理通知书的公告
T&KT&K(SZ:301263) Zheng Quan Ri Bao·2025-09-04 13:39

Core Points - Tianen Pharmaceutical announced that its wholly-owned subsidiary, Anhui Tianen Pharmaceutical Co., Ltd., has received the acceptance notice for the drug registration application for Dienogest tablets from the National Medical Products Administration (NMPA) [2] Group 1 - The NMPA has reviewed and accepted the drug registration application for Dienogest tablets based on Article 32 of the Administrative Licensing Law of the People's Republic of China [2]